Likewise, similar outcomes were also observed in liver cancer, nasopharyngeal cancer, gastric cancer, prostate cancer, and colorectal cancer, in which the EMT process seemed to be reversed due to the presence of FOXA1 [46]. This evidence concerns the gene FOXA1 and nasopharyngeal carcinoma.